查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1195994

血流測量設備市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Blood Flow Measurement Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2023 年至 2028 年），血流測量設備市場預計將以 9.2% 的複合年增長率增長。

COVID-19 大流行給醫療保健系統帶來了巨大挑戰。 在 COVID-19 大流行期間，大多數慢性病護理被認為是非緊急護理，因此所有門診護理都被推遲或限制，以降低病毒傳播的風險。 用於家庭監測 COVID-19 患者脈搏血氧飽和度、呼氣流量和體溫的應急系統。” 2021 年 3 月在 PLOS One 期刊上發表的“開發和初步應用”描述了用於監測 COVID-19 患者的應急系統的開發和評估，該系統也可用於醫院。 預計 COVID-19 大流行期間的此類發展將在預測期內推動血流測量設備市場的增長。

包括心血管疾病在內的主要慢性病在全球範圍內呈上升趨勢，這推動了血流測量設備市場的增長。 隨著風險的增加，也有有效的診斷方法可以對患者進行治療和監測。 心血管疾病患病率的增加在醫療保健中發揮著重要作用。 此外，由於心髒病的增加，越來越多的因素正在增加血流測量設備的市場份額。 例如，根據 2021 年 12 月發表的“印度老年人中的心血管疾病 (CVD) 及其相關風險因素”研究，標題為“印度老年人中的心血管疾病 (CVD) 及其相關風險因素”。 來自 LASI Wave 1 的證據”，在印度 45 歲及以上的人群中，自我報告的診斷為 CVD 的總體患病率為 29.4%。 同樣的數據還發現，年齡與較高的 CVD 風險相關，老年女性的 CVD 患病率高於老年男性。 因此，心血管疾病的高負擔有望在所研究的市場中發揮主要作用。

一些專注於創新血流測量設備的研發研究也在推動血流測量市場的增長。 例如，2020 年 9 月，印度政府科技部的一篇文章介紹了 Sree ChitraTirunal 醫學科學與技術研究所的一個研究團隊開發的一種新的具有成本效益的血流計設備。 研究人員發現，這款手掌大小的設備使用新穎的磁方法和信號調節技術測量血流量，符合國家和國際標準和指南，並且來自成熟的國內供應鏈。表明該產品是使用 這種在血流測量設備設計和製造方面的新穎研究有望在預測期內推動市場的增長。 然而，血流測量的高成本和有限的報銷方案預計將阻礙預測期內的市場增長。

血流測量設備的市場趨勢

在血流測量設備市場，超聲多普勒部分有望佔據主要市場份額。

超聲多普勒是血流測量設備市場的一個主要部分。 BJA Education 2020 年 4 月發表的題為“Essential notes on the physics of Doppler ultrasound”的論文描述了低能量、非電離波形的超聲波在醫學成像、治療和血流速度測量中的應用。它有有人指出，使用超聲波能量吸收會導致輕微的局部組織加熱，並且超聲波暴露被認為比其他診斷成像設備危險性更小。 超聲多普勒相對於其他血流測量設備的巨大優勢預計將在預測期內推動該細分市場的增長。

2020 年 12 月在 Ultrasonography 上發表的另一篇題為“Doppler sonography in aesthetic medicine”的文章描述了多普勒超聲在皮膚和美容藥物血流測量中的好處。 . 這篇文章表明，成像皮膚血管目前很少見，但在美容領域是一種非常有用的方法。 在預測期內，多普勒超聲在各個醫療領域的使用越來越多，預計將刺激血流測量設備市場這一細分市場的增長。

此外，在2020年5月發表於英國放射學雜誌的文章《多普勒超聲、CT和MRI對布加綜合徵的診斷準確性：系統評價和薈萃分析》中，布加綜合徵（BCS）的診斷對多普勒超聲、CT 和 MRI 的敏感性、特異性和診斷優勢比 (DOR) 進行了評估。 該論文表明，對於疑似 BCS 患者，多普勒是一種優越的一線影像學檢查。 多普勒超聲的優勢在於其可用性和低成本。 多普勒超聲還提供有關狹窄的功能信息。 這些優勢正在推動研究期間的市場增長。

此外，市場上推出新型血流測量設備將在預測期內刺激該細分市場的增長。 例如，2021年8月，Trivitron推出了SonoRad V60 Ultrasound，致力於提供卓越的成像系統和出色的圖像質量。 該設備採用創新的 Colorflow 技術，可改善血流的可視化。 預計此類產品的推出將推動預測期內所研究市場的增長。

預計在預測期內北美將佔據很大的市場份額

在血流測量設備製造中越來越多地採用先進技術和系統，以及血流研究領域的技術進步預計將推動北美地區的市場增長。 人們對市場上創新血流測量設備的可用性的高度認識有助於該地區的高市場增長。

北美地區慢性病患者患病率上升正在刺激血流測量設備市場的增長。 例如，根據 GLOBOCAN 2020 報告，2020 年北美地區報告了約 260 萬例癌症病例，預計到 2040 年將增加到 350 萬例。 同樣，根據美國疾病控制和預防中心 (CDC) 2022 年 7 月更新，美國每年記錄大約 805,000 例心髒病發作病例，其中 605,000 例是首次心髒病發作患者。其餘 200,000 例已經以前有過心髒病發作。 根據同一數據，五分之一的心髒病發作是“無聲的發作”，這意味著一個人心髒病發作但沒有意識到。 因此，慢性病的高負擔將推動該地區對包括血流測量在內的診斷的需求，這有望在預測期內推動市場增長。

2021 年 1 月，Nuralogix 發布了 Anura，這是一款無需袖帶或其他可穿戴設備即可進行非接觸式血壓測量的應用程序。 Anura 以醫療級精度測量身體、生理和心理指標，例如心率、壓力水平、BMI 和心血管疾病風險。 此類創新設備的推出有望推動市場增長。 因此，眾所周知，對血流測量設備的需求不斷增長，加上醫療領域投資的增加，將推動該地區的市場增長。

血流測量設備市場競爭者分析

血流測量設備市場競爭激烈，由幾家主要參與者組成。 從市場份額的角度來看，一些主要參與者目前主導著市場。 目前主導市場的公司包括 Cook Group Incorporated、Medistim ASA、Compumedics、Deltex Medical Group、Perimed AB、ADInstruments、Atys Medical、Moor Instruments Ltd.、SONOTEC GmbH、Transonic 等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 心血管疾病患病率上升和老年人口增加
    • 產品技術進步
  • 市場製約因素
    • 血流測量設備成本高
    • 有限的贖回方案
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於金額，單位：百萬美元）

  • 按產品分類
    • 超聲診斷設備
      • 超聲多普勒
      • 時差流量計
    • 激光多普勒
  • 通過申請
    • 血管內治療
      • 微血管手術
      • 冠狀動脈搭橋手術
      • 其他
    • 非侵入性
      • 心血管疾病
      • 胃腸病學
      • 腫瘤監測
      • 其他
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Cook Group Incorporated
    • Medistim ASA
    • Compumedics
    • Deltex Medical Group
    • Perimed AB
    • ADInstruments
    • Atys Medical
    • Moor Instruments Ltd.
    • SONOTEC GmbH
    • Transonic
    • Carolina Medical Inc.
    • ArjoHuntleigh, Inc.

第7章 市場機會與今後動向

簡介目錄
Product Code: 68127

The blood flow measurement devices market is projected to register a CAGR of 9.2% during the forecast period (2023 - 2028).

The healthcare system has witnessed enormous challenges because of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. An article titled "An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application" published in the journal PLOS One in March 2021 discussed the development and evaluation of an emergency system for monitoring patients with COVID-19, which may be useful in hospitals. Such developments in the time of the COVID-19 pandemic are expected to propel the growth of the blood flow measurement devices market in the forecast period.

Major chronic diseases including cardiovascular diseases are on the rise all over the world, which is adding to the growth of the blood flow measurement devices market. With increasing risks, there are also effective diagnostics that lead to the treatment and monitoring of patients. The rise in the number of cardiovascular disease cases plays an important role in healthcare. In addition, the growing number of factors attributing to the rise in cardiac diseases is increasing the market share for the blood flow measurement devices segment. For instance, according to the research study published in December 2021, titled "Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1", for older persons in India who were 45 years of age and above, the overall self-reported prevalence of diagnosed CVDs was 29.4%. also, as per the same source, age was linked to a higher risk of CVD and female older individuals had a higher CVD prevalence than male older adults. Hence, the high burden of cardiovascular diseases is expected to play a major role in the studied market.

Several research and development studies focusing on innovative blood flow measurement devices are also adding to the growth of the blood flow device measurement market. For instance, in September 2020, the Government of India Ministry of Science & Technology's article discussed a new cost-effective blood flow meter device by a team of researchers at the Sree ChitraTirunal Institute for Medical Sciences and Technology. The researchers indicated that the palm-sized device measures the flow rate of blood using a novel magnetic method and a signal conditioning technique and is compliant with national and international standards and guidelines and is manufactured using components sourced from established supply chains within the country. Such novel research in the design and manufacturing of blood flow measurement devices is expected to boost the growth of the studied market in the forecast period. However, the high cost of the blood flow measurement and limited reimbursement scenario are expected to hamper the market growth over the forecast period.

Blood Flow Measurement Devices Market Trends

Ultrasound Dopplers Segment is Expected to Hold a Major Market Share in the Blood Flow Measurement Devices Market.

Ultrasound dopplers hold the major segment in the blood flow measurement devices market. An article titled "Essential notes on the physics of Doppler ultrasound" presented in the journal of BJA Education in April 2020 indicated that the use of low energy, non-ionizing waveform ultrasound in medicine for imaging, therapy, and measurement of blood velocity means that ultrasound exposures are thought to be less hazardous than other imaging modalities, though mild local tissue heating occurs with the absorption of ultrasound energy. The huge advantages of ultrasound dopplers over other blood flow measurement devices are expected to propel the growth of the segment in the forecast period.

Another article published in the journal of Ultrasonography in December 2020 titled "Usefulness of Doppler sonography in aesthetic medicine" discussed the advantages of ultrasound dopplers in blood flow measurement for dermal and aesthetic medicines. The article indicated that though the imaging of skin vessels is currently rare, the method is very useful in the aesthetics division. The rise in the use of ultrasound dopplers in various medical sectors is expected to add to the growth of the segment in the blood flow measurement devices market in the forecast period.

Also, an article titled "Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis" presented in the British Journal of Radiology in May 2020 evaluated the sensitivity, specificity, and diagnostic odds ratio (DOR) of Doppler ultrasound, CT, and MRI in the diagnosis of Budd Chiari syndrome (BCS). The article suggested that Doppler is an excellent first-line imaging test for patients suspected to have BCS. The advantages of Doppler ultrasound are easy availability and lower cost. Doppler ultrasound also provides functional information regarding stenosis. Such advantages are driving the growth of the market in the study period.

Also, the launch of novel blood flow measurement devices in the market is adding to the segment's growth over the forecast period. For instance, in August 2021, Trivitron launched SonoRad V60 Ultrasound devoted to delivering excellent imaging systems and exceptional image quality. The device is equipped with innovative color flow technology that improves blood flow visualization. Such product launches are expected to boost the growth of the studied market during the forecast period.

North America is Expected to Hold a Significant Share in the Market Over Forecast Period

The rise in the adoption of highly advanced techniques and systems in the manufacturing of blood flow measurement devices and the technological advancements made in blood flow studies is expected to boost the growth of the market in the North American region. The high awareness among the population on the availability of innovative blood flow measurement devices in the market contributes to the high market growth in the region.

The rising prevalence of chronic disease cases in the North American region is adding to the growth of the blood flow measurement devices market. For instance, according to the GLOBOCAN 2020 report, about 2.6 million cases of cancer were reported in Northern America region in 2020, which is further projected to increase to 3.5 million cases by 2040. Similarly, according to the July 2022 update of the Centers for Disease Control and Prevention (CDC), approximately 805,000 heart attack incidences are recorded every year in the United States, of which 605,000 people had a heart attack the first time and the remaining 200,000 were those who already had a heart attack before. Further as per the same source, about 1 in 5 heart attacks are silent which means the person had a heart attack but was not aware of it. Hence, the high burden of chronic diseases is expected to increase the requirement of diagnosis including blood flow measurement in the region which is expected to boost market growth over the forecast period.

In January 2021, Nuralogix launched their app Anura, allowing for contactless blood pressure measurement, without the need for cuffs or other wearables. Anura measures physical, physiological, and psychological indexes, including heart rate, stress levels, BMI, and cardiovascular disease risks with medical grade accuracy. The launch of such innovative devices is expected to boost the growth of the market. Thus, the increasing necessity for blood flow measurement devices coupled with increasing investment in the health care department is known to propel the growth of the market in this region.

Blood Flow Measurement Devices Market Competitor Analysis

The blood flow measurement devices market is fairly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market areCook Group Incorporated, Medistim ASA, Compumedics, Deltex Medical Group, Perimed AB, ADInstruments, Atys Medical, Moor Instruments Ltd., SONOTEC GmbH, Transonic and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases and Growing Geriatric Population
    • 4.2.2 Advancements in Product Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Blood Flow Measurement Devices
    • 4.3.2 Limited Reimbursement Scenario
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product
    • 5.1.1 Ultrasound Devices
      • 5.1.1.1 Ultrasound Doppler
      • 5.1.1.2 Transit-Time Flow Meters
    • 5.1.2 Laser Doppler
  • 5.2 By Application
    • 5.2.1 Invasive
      • 5.2.1.1 Microvascular Surgery
      • 5.2.1.2 Coronary Artery Bypass Surgery
      • 5.2.1.3 Others
    • 5.2.2 Non-Invasive
      • 5.2.2.1 Cardiovascular Disease
      • 5.2.2.2 Gastroenterology
      • 5.2.2.3 Tumor Monitoring
      • 5.2.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cook Group Incorporated
    • 6.1.2 Medistim ASA
    • 6.1.3 Compumedics
    • 6.1.4 Deltex Medical Group
    • 6.1.5 Perimed AB
    • 6.1.6 ADInstruments
    • 6.1.7 Atys Medical
    • 6.1.8 Moor Instruments Ltd.
    • 6.1.9 SONOTEC GmbH
    • 6.1.10 Transonic
    • 6.1.11 Carolina Medical Inc.
    • 6.1.12 ArjoHuntleigh, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS